Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04852601 · ClinicalTrials.gov registry record · NA

ToolBox Detect: Low Cost Detection of Cognitive Decline in Primary Care Settings

A NA study of Dementia and Cognitive Dysfunction, sponsored by Northwestern University.

Active
Registry status
NA
Development phase
41,500
Enrollment target
1
Study location

NCT04852601 is a NA study of Dementia and Cognitive Dysfunction that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 41,500 participants, above the 7,514-participant average among 199 other Dementia trials with a reported enrollment target (452% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04852601, a NA study of Dementia and Cognitive Dysfunction, is active but no longer recruiting, sponsored by Northwestern University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
41,500 participants
Enrollment target
1
Study location

Study Summary

Our study objective is to widely implement and evaluate a user-centered, scalable, electronic health record (EHR)-linked strategy for the routine detection of cognitive decline among diverse primary care settings. This strategy, called ToolboxDetect, will provide an efficient and sensitive cognitive screen that can be easily implemented in everyday clinical settings, and is responsive to patient, family, and caregiver concerns for potential symptoms of cognitive decline (CD) and cognitive impairment (CI).

Interventions

  • OTHER ToolboxDetect

Study Locations (1)

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 41,500 participants
Start Date 2022-08-25
Est. Completion 2026-05
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT04852601

The ClinicalTrials.gov registry entry for NCT04852601 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 41,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 7,514-participant average among 199 other Dementia trials with a reported enrollment target (452% higher). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Dementia appearing as the primary indexed condition, and to 1 intervention - of which ToolboxDetect is the first listed.

NCT04852601 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04852601 about?

NCT04852601 is a clinical study titled "ToolBox Detect: Low Cost Detection of Cognitive Decline in Primary Care Settings". Our study objective is to widely implement and evaluate a user-centered, scalable, electronic health record (EHR)-linked strategy for the routine detection of cognitive decline among diverse primary care settings. This strategy, called ToolboxDetect, will provide an efficient and sensitive cognitive...

What is the current status of trial NCT04852601?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 41,500 participants. The study started on 2022-08-25. Estimated completion is 2026-05.

What conditions does trial NCT04852601 study?

This clinical trial studies the following conditions: Dementia, Cognitive Dysfunction.

What interventions are being tested in trial NCT04852601?

The interventions under investigation include: ToolboxDetect (OTHER).

Who is sponsoring clinical trial NCT04852601?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04852601 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dementia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.